Profound Medical, Siemens Healthineers enter co-sales, co-marketing agreement

Profound Medical (PROF) entered into a definitive co-sales and co-marketing agreement with Siemens Healthineers (SIEGY) pursuant to which the companies will commercialize a new MRI-guided prostate therapy solution which combines Profound’s TULSA-PRO system and consumables with Siemens Healthineers’ Magnetom Free.Max magnetic resonance scanner. Subject to the completion of the compatibility process of TULSA-PRO and Magnetom Free.Max, the companies currently expect to initiate sales of the total prostate solution in 2025.